Valuation Biogen Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 06/02/2026 GMT			5-day change	1st Jan Change
201.18 ^USD	+8.53%		+11.84%	+14.31%

02-06	Stifel Nicolaus Adjusts Biogen PT to $214 From $202, Maintains Buy Rating	MT
02-06	Biogen Inc., Q4 2025 Earnings Call, Feb 06, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	35,242	39,877	37,495	22,283	25,818	29,525	-	-
Change	-	13.15%	-5.97%	-40.57%	15.86%	14.36%	-	-
Enterprise Value (EV) ¹	37,820	40,560	43,384	26,204	25,818	29,369	26,020	23,683
Change	-	7.24%	6.96%	-39.6%	-1.47%	13.75%	-11.4%	-8.98%
P/E ratio	23.1x	13.3x	32.5x	13.7x	20x	16.7x	15.1x	13.2x
PBR	3.26x	3.02x	2.53x	1.33x	-	1.45x	1.32x	1.21x
PEG	-	0x	-0.5x	0.3x	-0.9x	0.5x	1.4x	0.9x
Capitalization / Revenue	3.21x	3.92x	3.81x	2.3x	2.61x	3.15x	3.17x	3.14x
EV / Revenue	3.44x	3.99x	4.41x	2.71x	2.61x	3.14x	2.79x	2.52x
EV / EBITDA	9.13x	11.2x	14.3x	7.1x	-	9.08x	8.17x	7.7x
EV / EBIT	10.3x	13.1x	17x	8.69x	9.1x	10.3x	8.94x	7.9x
EV / FCF	11.2x	35.5x	34.2x	9.63x	-	10.9x	9.92x	8.23x
FCF Yield	8.94%	2.82%	2.93%	10.4%	-	9.16%	10.1%	12.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	10.4	20.87	7.97	11.18	8.79	12.04	13.32	15.27
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	10,982	10,173	9,836	9,676	9,891	9,366	9,319	9,406
EBITDA ¹	4,144	3,618	3,040	3,689	-	3,234	3,183	3,076
EBIT ¹	3,656	3,099	2,545	3,015	2,838	2,848	2,911	2,997
Net income ¹	1,556	3,047	1,161	1,632	1,293	1,813	2,036	2,124
Net Debt ¹	2,578	683	5,888	3,921	-	-156	-3,504	-5,842
Reference price ²	239.92	276.92	258.77	152.92	175.99	201.18	201.18	201.18
Nbr of stocks (in thousands)	146,893	144,001	144,898	145,719	146,702	146,759	-	-
Announcement Date	03/02/22	15/02/23	13/02/24	12/02/25	06/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOGEN INC.	16.66x	3.28x	9.56x	-.--%	29.52B
REGENERON PHARMACEUTICALS, INC.	19.89x	4.62x	12.7x	0.5%	80.61B
CSL LIMITED	24.12x	4.35x	12.65x	2.44%	61B
UCB	41.98x	6.59x	20.94x	0.54%	58.81B
SAMSUNG BIOLOGICS CO.,LTD.	50.25x	13.26x	28.45x	-.--%	52.77B
INCYTE CORPORATION	17.51x	3.47x	10.37x	-.--%	21.28B
INNOVENT BIOLOGICS, INC.	73.24x	8.58x	82.3x	-.--%	17.65B
MODERNA, INC.	-5.2x	5.95x	-3.57x	-.--%	16.02B
SWEDISH ORPHAN BIOVITRUM AB	666.07x	5.19x	13.27x	-.--%	15.17B
Average	100.50x	6.14x	20.74x	0.39%	39.2B
Weighted average by Cap.	57.75x	6.30x	18.78x	0.63%